You have 9 free searches left this month | to do more

tti-622

Tti 622 is a drug used to treat Multiple Myeloma, Acute Myeloid Leukemia, Diffuse Large B-Cell Lymphoma, and other conditions. Tti 622 is being actively studied in 3 studies; no studies for this drug have been completed so far.

Top SponsorsTop SitesTop Investigators
Trillium Therapeutics Inc.Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer CenterBarbara Ann Karmanos Cancer Institute
Gabrail Cancer Center Research, LLC
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Recruiting
  • Ovarian Cancer
  • +5 more
  • TTI-622
  • Pegylated Liposomal Doxorubicin
  • Houston, Texas
    Oncology Consultants, P.A.
2022-03-14
Mar 14, 2022
M
Recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
2022-02-02
Feb 2, 2022
T
Recruiting
  • Lymphoma
  • +3 more
  • TTI-622
  • +5 more
  • Los Angeles, California
  • +13 more
2022-03-28
Mar 28, 2022